Consint.AI Raises ₹22 Cr for AI Fraud Detection

Consint.AI, a specialist in deeptech artificial intelligence for risk management in healthcare and insurance, has successfully closed a Series A funding round, securing ₹22 crore. This significant capital infusion is earmarked to propel the company's global expansion, enhance its AI research capabilities, and bolster its enterprise delivery infrastructure.

The funding round saw participation from notable technology investors, including BIG Global Investment JSC, Equanimity Ventures Trust II, and Seafund Venture India Scheme I. This backing underscores the market's confidence in Consint.AI's innovative approach to tackling complex challenges within the financial services and healthcare sectors.

A primary objective for the newly acquired capital is the accelerated development of a foundational AI model specifically engineered for the detection of fraud, waste, and abuse (FWA). This advanced model aims to deliver superior accuracy and faster processing times, while also ensuring data sovereignty for clients across the insurance, banking, and financial services industries. The company's existing track record includes assessing over 100 million transactions and identifying approximately ₹10 billion in fraudulent activities using a suite of over 500 AI/ML models.

“This funding represents a powerful endorsement of our mission to revolutionize healthcare and insurance operations through AI,” stated Ashish Chaturvedi, Founder and CEO of Consint.AI. “A substantial portion of these funds will be dedicated to building a specialized foundational model for FWA detection, a critical area where we aim to achieve deep expertise. This will enable us to expand our global reach and provide intelligent solutions that mitigate risk and enhance efficiency for our clients.”

The strategic deployment of funds will also focus on expanding Consint.AI's portfolio of AI-powered solutions, with a particular emphasis on claims processing, document forensics, and clinical intelligence. The company plans to broaden its operational footprint across key international markets, including India, the Middle East, Africa, the United States, and Southeast Asia, reflecting its global ambitions.

Preeti Chaturvedi, COO of Consint.AI, highlighted the company's commitment to delivering tangible value: “Crossing this funding milestone validates the robust operational foundation we've established. This investment will empower us to strengthen our delivery capabilities, scale our global operations, and continue developing secure, enterprise-ready AI platforms that address real-world challenges for healthcare providers and insurers.”

The investment community expressed strong optimism. BIG Global Investment JSC noted the immense growth potential in addressing fraud and waste in healthcare claims processing, anticipating that Consint.AI's success will redirect resources to patients and improve overall healthcare quality. Equanimity Ventures Trust II emphasized their focus on backing technology-led businesses with enduring impact, citing Consint.AI's innovation and customer traction as key factors. Seafund Venture India Scheme I reiterated its commitment to nurturing high-potential, innovation-driven ventures.